BioPrintIA

BioPrintIA

ReadyCell collaborates in the BioPrintIA project as a specialized partner in the biotechnology sector. BioPrintIA is a subsidised R&D project that develops a next-generation medical device based on artificial intelligence, 3D bioprinting and personalized...
Pharmacology 2020 Event

Pharmacology 2020 Event

ReadyCell actively interacts with the Drug Discovery community, introducing cell-based in vitro systems and easing novel compounds’ preclinical development.
PreadyTake MATE1, Screening Renal and Hepatic Drug Metabolism

PreadyTake MATE1, Screening Renal and Hepatic Drug Metabolism

The liver and the kidneys have clearly defined various physiologic functions, their role as excretory organs for drugs and chemicals and their polar metabolites are well described.  These organs have a relevant impact on the biotransformation of a variety of chemicals...